Read More Pharma Industry News Gilead Sciences to acquire immuno-oncology company Forty Seven for $4.9bn Gilead Sciences acquisition of Forty Seven : US biotech company Gilead Sciences has signed an all-cash deal worth… bypharmanewsdailyMarch 3, 2020